Assuming successful trial results, Maxim Group's OCT 2019 report estimated revenues for IMP321 (Breast Cancer) from milestones and royalties to start in 2022? Although I am not inclined to focus too much on these reports, to what extent do the upcoming results influence these dates (e.g good results - fast track, ok results - another trial?)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.3¢ |
Change
-0.008(3.00%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 24.0¢ | $348.2K | 1.447M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 38414 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 73763 | 7 |
View Market Depth
| Last trade - 11.56am 04/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |